Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Congestive Heart Failure
100%
Clinical Response
100%
Hemodynamic Response
100%
Enalapril
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Hg(p)
57%
Cardiac Index
28%
Mean Arterial Pressure
28%
Right Atrial Pressure
28%
Vasodilator
14%
Long-term Administration
14%
Long-term Treatment
14%
Peak Effect
14%
Pulmonary Capillary Wedge Pressure
14%
Renal Blood Flow
14%
Maximal Oxygen Uptake
14%
Exercise Duration
14%
Captopril
14%
Regional Blood Flow
14%
Pulmonary Artery Pressure
14%
Plasma Renin Activity
14%
Toxic Side Effects
14%
Hemodynamic Assessment
14%
Symptomatic Improvement
14%
Pulmonary Resistance
14%
Persistent Effects
14%
Hear Failure
14%
Medicine and Dentistry
Hemodynamic
100%
ACE Inhibitor
100%
Enalapril
100%
Patient with Congestive Heart Failure
100%
Mean Arterial Pressure
28%
Heart Right Atrium Pressure
28%
Oral
28%
Blood Flow
14%
Noradrenalin
14%
Congestive Heart Failure
14%
Kidney Blood Flow
14%
Lung Artery Pressure
14%
Pulmonary Artery Occlusion Pressure
14%
Oxygen Consumption
14%
Pulmonary Resistance
14%
Captopril
14%
Renin
14%
Side Effect
14%
Biochemistry, Genetics and Molecular Biology
Enzyme Inhibitor
100%
Hemodynamic
100%
Mean Arterial Pressure
50%
Heart Right Atrium Pressure
50%
Angiotensin-Converting Enzyme
25%
Plasma Renin Activity
25%
Blood Flow
25%
Kidney Blood Flow
25%
Oxygen Consumption
25%
Noradrenalin Blood Level
25%
Lung Artery Pressure
25%
Pulmonary Artery Occlusion Pressure
25%
Captopril
25%
Pharmacology, Toxicology and Pharmaceutical Science
Dipeptidyl Carboxypeptidase Inhibitor
100%
Congestive Heart Failure
100%
Enalapril
100%
Captopril
14%
Noradrenalin
14%
Renin
14%
Side Effect
14%